<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35467259</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1559-1182</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>25</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecular neurobiology</Title>
          <ISOAbbreviation>Mol Neurobiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>PPARγ Dysfunction in the Medial Prefrontal Cortex Mediates High-Fat Diet-Induced Depression.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-022-02806-6</ELocationID>
        <Abstract>
          <AbstractText>Epidemiological studies suggest a bidirectional association between depression and obesity; however, the biological mechanisms that link the development of depression to a metabolic disorder remain unclear. Even though nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) agonists show anti-depressive effect, and high-fat diet-(HFD)-induced PPARγ dysfunction is involved in the pathogenesis of metabolic disorders, the neuronal PPARγ has never been studied in HFD-induced depression. Thus, we aimed to investigate the effect of neuronal PPARγ on depressive-like behaviors in HFD-induced obese mice.We fed male C57BL/6 J mice with HFD to generate obese mice and conducted a series of behavioral tests to assess the effects of HFD feeding on depression. We generated neuron-specific PPARγ knockout mice (NKO) to determine whether neuronal PPARγ deficiency was correlated with depressive-like behaviors. To further prove whether PPARγ in the medial prefrontal cortex (mPFC) neurons is involved in depressive-like behaviors, we applied AAV- CaMKIIα-Cre approach to specifically knockout PPARγ in the mPFC neurons of LoxP mice and used AAV-syn-PPARγ vectors to overexpress PPARγ in the mPFC neurons of NKO mice.We observed a low mPFC PPARγ level and an increase in depressive-like behaviors in the HFD-fed mice. Moreover, neuronal-specific PPARγ deficiency in mice induced depressive-like behaviors, which could be abolished by imipramine. Furthermore, overexpressing PPARγ in the mPFC reversed the depressive-like behaviors in HFD-fed mice as well as in neuronal-specific PPARγ knockout mice.These results implicate that dysregulation of neuronal PPARγ in the mPFC may contribute to an increased risk for depression in obese populations.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fu</LastName>
            <ForeName>Cong-Cong</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xin-Yi</ForeName>
            <Initials>XY</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Liu</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Hui-Xian</ForeName>
            <Initials>HX</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Shuang</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wu</LastName>
            <ForeName>Qiao-Qi</ForeName>
            <Initials>QQ</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Zhen</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gu</LastName>
            <ForeName>Xi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Li-Fang</ForeName>
            <Initials>LF</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lin</LastName>
            <ForeName>Song</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fang</LastName>
            <ForeName>Ying-Ying</ForeName>
            <Initials>YY</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cao</LastName>
            <ForeName>Xiong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xuemin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangdong Province Key Laboratory of Psychiatric Disorders, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. xmwang@smu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>25</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Mol Neurobiol</MedlineTA>
        <NlmUniqueID>8900963</NlmUniqueID>
        <ISSNLinking>0893-7648</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Depression</Keyword>
        <Keyword MajorTopicYN="N">High-fat diet</Keyword>
        <Keyword MajorTopicYN="N">Medial prefrontal cortex</Keyword>
        <Keyword MajorTopicYN="N">Obesity</Keyword>
        <Keyword MajorTopicYN="N">PPARγ</Keyword>
        <Keyword MajorTopicYN="N">Rosiglitazone</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>25</Day>
          <Hour>12</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35467259</ArticleId>
        <ArticleId IdType="doi">10.1007/s12035-022-02806-6</ArticleId>
        <ArticleId IdType="pii">10.1007/s12035-022-02806-6</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455(7215):894–902. https://doi.org/10.1038/nature07455</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature07455</ArticleId>
            <ArticleId IdType="pubmed">18923511</ArticleId>
            <ArticleId IdType="pmc">2721780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7(2):137–151. https://doi.org/10.1038/nrn1846</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn1846</ArticleId>
            <ArticleId IdType="pubmed">16429123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castren E (2013) Neuronal network plasticity and recovery from depression. JAMA Psychiat 70(9):983–989. https://doi.org/10.1001/jamapsychiatry.2013.1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2013.1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan A, Sun Q, Czernichow S, Kivimaki M, Okereke OI, Lucas M, Manson JE, Ascherio A, Hu FB (2012) Bidirectional association between depression and obesity in middle-aged and older women. Int J Obes 36(4):595–602. https://doi.org/10.1038/ijo.2011.111</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ijo.2011.111</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6):1069–1078</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diacare.24.6.1069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG (2010) Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 67(3):220–229. https://doi.org/10.1001/archgenpsychiatry.2010.2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archgenpsychiatry.2010.2</ArticleId>
            <ArticleId IdType="pubmed">20194822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hryhorczuk C, Sharma S, Fulton SE (2013) Metabolic disturbances connecting obesity and depression. Front Neurosci 7:177. https://doi.org/10.3389/fnins.2013.00177</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2013.00177</ArticleId>
            <ArticleId IdType="pubmed">24109426</ArticleId>
            <ArticleId IdType="pmc">3791387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, Maisano C, Jones L, Murrah NV, Vaccarino V (2008) Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiat 64(10):896–900. https://doi.org/10.1016/j.biopsych.2008.05.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2008.05.019</ArticleId>
            <ArticleId IdType="pubmed">18597739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willson TM, Lambert MH, Kliewer SA (2001) Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem 70:341–367. https://doi.org/10.1146/annurev.biochem.70.1.341</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.biochem.70.1.341</ArticleId>
            <ArticleId IdType="pubmed">11395411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Bluher M, Griffin PR, Spiegelman BM (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466(7305):451–456. https://doi.org/10.1038/nature09291</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature09291</ArticleId>
            <ArticleId IdType="pubmed">20651683</ArticleId>
            <ArticleId IdType="pmc">2987584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji-Rong Y, Bi-Rong D, Chang-Quan H, Zhen-Chan L, Hong-Mei W, Yan-Ling Z, Mattis TA (2009) Pro12Ala polymorphism in PPARgamma2 associated with depression in Chinese nonagenarians/centenarians. Arch Med Res 40(5):411–415. https://doi.org/10.1016/j.arcmed.2009.05.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.arcmed.2009.05.005</ArticleId>
            <ArticleId IdType="pubmed">19766907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eissa Ahmed AA, Al-Rasheed NM, Al-Rasheed NM (2009) Antidepressant-like effects of rosiglitazone, a PPARgamma agonist, in the rat forced swim and mouse tail suspension tests. Behav Pharmacol 20(7):635–642. https://doi.org/10.1097/FBP.0b013e328331b9bf</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/FBP.0b013e328331b9bf</ArticleId>
            <ArticleId IdType="pubmed">19745723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo M, Li C, Lei Y, Xu S, Zhao D, Lu XY (2017) Role of the adipose PPARgamma-adiponectin axis in susceptibility to stress and depression/anxiety-related behaviors. Mol Psychiatry 22(7):1056–1068. https://doi.org/10.1038/mp.2016.225</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2016.225</ArticleId>
            <ArticleId IdType="pubmed">27956741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou L, Yin J, Wang C, Liao J, Liu G, Chen L (2014) Lack of seipin in neurons results in anxiety- and depression-like behaviors via down regulation of PPARgamma. Hum Mol Genet 23(15):4094–4102. https://doi.org/10.1093/hmg/ddu126</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddu126</ArticleId>
            <ArticleId IdType="pubmed">24651066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casanova E, Fehsenfeld S, Mantamadiotis T, Lemberger T, Greiner E, Stewart AF, Schutz G (2001) A CamKIIalpha iCre BAC allows brain-specific gene inactivation. Genesis 31(1):37–42. https://doi.org/10.1002/gene.1078</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/gene.1078</ArticleId>
            <ArticleId IdType="pubmed">11668676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao X, Strong R, Zhang J, Sun G, Tsien JZ, Cui Z, Grotta JC, Aronowski J (2009) Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. The Journal of neuroscience : the official journal of the Society for Neuroscience 29(19):6186–6195. https://doi.org/10.1523/JNEUROSCI.5857-08.2009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.5857-08.2009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y, Qin X, Liu S, Li J, Zhu X, Gao T, Wang X (2011) Peroxisome proliferator-activated receptor gamma is inhibited by histone deacetylase 4 in cortical neurons under oxidative stress. J Neurochem 118(3):429–439. https://doi.org/10.1111/j.1471-4159.2011.07316.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-4159.2011.07316.x</ArticleId>
            <ArticleId IdType="pubmed">21605119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao X, Li LP, Wang Q, Wu Q, Hu HH, Zhang M, Fang YY, Zhang J, Li SJ, Xiong WC, Yan HC, Gao YB, Liu JH, Li XW, Sun LR, Zeng YN, Zhu XH, Gao TM (2013) Astrocyte-derived ATP modulates depressive-like behaviors. Nat Med 19(6):773–777. https://doi.org/10.1038/nm.3162</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3162</ArticleId>
            <ArticleId IdType="pubmed">23644515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin XH, Wu Z, Dong JH, Zeng YN, Xiong WC, Liu C, Wang MY, Zhu MZ, Chen WJ, Zhang Y, Huang QY, Zhu XH (2019) Liver soluble epoxide hydrolase regulates behavioral and cellular effects of chronic stress. Cell reports 29 (10):3223–3234 e3226. https://doi.org/10.1016/j.celrep.2019.11.006</Citation>
        </Reference>
        <Reference>
          <Citation>Lam YY, Tsai SF, Chen PC, Kuo YM, Chen YW (2021) Pioglitazone rescues high-fat diet-induced depression-like phenotypes and hippocampal astrocytic deficits in mice. Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie 140:111734. https://doi.org/10.1016/j.biopha.2021.111734</Citation>
        </Reference>
        <Reference>
          <Citation>Cheng Y, Rodriguiz RM, Murthy SR, Senatorov V, Thouennon E, Cawley NX, Aryal DK, Ahn S, Lecka-Czernik B, Wetsel WC, Loh YP (2015) Neurotrophic factor-alpha1 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone. Mol Psychiatry 20(6):744–754. https://doi.org/10.1038/mp.2014.136</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2014.136</ArticleId>
            <ArticleId IdType="pubmed">25330741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Can A, Dao DT, Arad M, Terrillion CE, Piantadosi SC, Gould TD (2012) The mouse forced swim test. Journal of visualized experiments : JoVE 59:e3638. https://doi.org/10.3791/3638</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3791/3638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85(3):367–370</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00428203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ribeiro MA, Aguiar RP, Scarante FF, Fusse EJ, de Oliveira RMW, Guimaraes FS, Campos AC (2021) Spontaneous activity of CB2 receptors attenuates stress-induced behavioral and neuroplastic deficits in male mice. Front Pharmacol 12:805758. https://doi.org/10.3389/fphar.2021.805758</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fphar.2021.805758</ArticleId>
            <ArticleId IdType="pubmed">35126139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Golden SA, Covington HE 3rd, Berton O, Russo SJ (2011) A standardized protocol for repeated social defeat stress in mice. Nat Protoc 6(8):1183–1191. https://doi.org/10.1038/nprot.2011.361</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nprot.2011.361</ArticleId>
            <ArticleId IdType="pubmed">21799487</ArticleId>
            <ArticleId IdType="pmc">3220278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirshenbaum GS, Saltzman K, Rose B, Petersen J, Vilsen B, Roder JC (2011) Decreased neuronal Na+, K+ -ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes Brain Behav 10(5):542–550. https://doi.org/10.1111/j.1601-183X.2011.00691.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1601-183X.2011.00691.x</ArticleId>
            <ArticleId IdType="pubmed">21418141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Q, Wu X, Yan S, Xie X, Fan Y, Zhang J, Peng C, You Z (2016) The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARgamma-mediated alteration of microglial activation phenotypes. J Neuroinflammation 13(1):259. https://doi.org/10.1186/s12974-016-0728-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12974-016-0728-y</ArticleId>
            <ArticleId IdType="pubmed">27716270</ArticleId>
            <ArticleId IdType="pmc">5051050</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang M, Radford KD, Driscoll M, Purnomo S, Kim J, Choi KH (2019) Effects of subanesthetic intravenous ketamine infusion on neuroplasticity-related proteins in the prefrontal cortex, amygdala, and hippocampus of Sprague-Dawley rats. IBRO reports 6:87–94. https://doi.org/10.1016/j.ibror.2019.01.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ibror.2019.01.006</ArticleId>
            <ArticleId IdType="pubmed">30723838</ArticleId>
            <ArticleId IdType="pmc">6350099</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Guo M, Zhang D, Cheng SY, Liu M, Ding J, Scherer PE, Liu F, Lu XY (2012) Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity. Proc Natl Acad Sci USA 109(30):12248–12253. https://doi.org/10.1073/pnas.1202835109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1202835109</ArticleId>
            <ArticleId IdType="pubmed">22778410</ArticleId>
            <ArticleId IdType="pmc">3409774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moreno S, Farioli-Vecchioli S, Ceru MP (2004) Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123(1):131–145. https://doi.org/10.1016/j.neuroscience.2003.08.064</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2003.08.064</ArticleId>
            <ArticleId IdType="pubmed">14667448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131(2):391–404. https://doi.org/10.1016/j.cell.2007.09.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2007.09.018</ArticleId>
            <ArticleId IdType="pubmed">17956738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu P, Chen A, Li Y, Xing X, Lu H (2019) Medial prefrontal cortex in neurological diseases. Physiol Genomics 51(9):432–442. https://doi.org/10.1152/physiolgenomics.00006.2019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physiolgenomics.00006.2019</ArticleId>
            <ArticleId IdType="pubmed">31373533</ArticleId>
            <ArticleId IdType="pmc">6766703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eckel-Mahan KL, Patel VR, de Mateo S, Orozco-Solis R, Ceglia NJ, Sahar S, Dilag-Penilla SA, Dyar KA, Baldi P, Sassone-Corsi P (2013) Reprogramming of the circadian clock by nutritional challenge. Cell 155(7):1464–1478. https://doi.org/10.1016/j.cell.2013.11.034</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2013.11.034</ArticleId>
            <ArticleId IdType="pubmed">24360271</ArticleId>
            <ArticleId IdType="pmc">4573395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kemp DE, Ismail-Beigi F, Calabrese JR (2009) Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome. Am J Psychiatry 166(5):619. https://doi.org/10.1176/appi.ajp.2008.08081195</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/appi.ajp.2008.08081195</ArticleId>
            <ArticleId IdType="pubmed">19411385</ArticleId>
            <ArticleId IdType="pmc">3904749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kemp DE, Ismail-Beigi F, Ganocy SJ, Conroy C, Gao K, Obral S, Fein E, Findling RL, Calabrese JR (2012) Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. J Affect Disord 136(3):1164–1173. https://doi.org/10.1016/j.jad.2011.06.033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jad.2011.06.033</ArticleId>
            <ArticleId IdType="pubmed">21782251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kariharan T, Nanayakkara G, Parameshwaran K, Bagasrawala I, Ahuja M, Abdel-Rahman E, Amin AT, Dhanasekaran M, Suppiramaniam V, Amin RH (2015) Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression. Neurobiol Aging 36(3):1451–1461. https://doi.org/10.1016/j.neurobiolaging.2014.09.028</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.09.028</ArticleId>
            <ArticleId IdType="pubmed">25510319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thouennon E, Cheng Y, Falahatian V, Cawley NX, Loh YP (2015) Rosiglitazone-activated PPARgamma induces neurotrophic factor-alpha1 transcription contributing to neuroprotection. J Neurochem 134(3):463–470. https://doi.org/10.1111/jnc.13152</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jnc.13152</ArticleId>
            <ArticleId IdType="pubmed">25940785</ArticleId>
            <ArticleId IdType="pmc">4496294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nenov MN, Laezza F, Haidacher SJ, Zhao Y, Sadygov RG, Starkey JM, Spratt H, Luxon BA, Dineley KT, Denner L (2014) Cognitive enhancing treatment with a PPARgamma agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice. The Journal of neuroscience : the official journal of the Society for Neuroscience 34(3):1028–1036. https://doi.org/10.1523/JNEUROSCI.3413-13.2014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3413-13.2014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torres RC, Magalhaes NS, PM ES, Martins MA, Carvalho VF, (2016) Activation of PPAR-gamma reduces HPA axis activity in diabetic rats by up-regulating PI3K expression. Exp Mol Pathol 101(2):290–301. https://doi.org/10.1016/j.yexmp.2016.10.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexmp.2016.10.002</ArticleId>
            <ArticleId IdType="pubmed">27725163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villapol S (2018) Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation. Cell Mol Neurobiol 38(1):121–132. https://doi.org/10.1007/s10571-017-0554-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10571-017-0554-5</ArticleId>
            <ArticleId IdType="pubmed">28975471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beurel E, Toups M, Nemeroff CB (2020) The bidirectional relationship of depression and inflammation: double trouble. Neuron 107(2):234–256. https://doi.org/10.1016/j.neuron.2020.06.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2020.06.002</ArticleId>
            <ArticleId IdType="pubmed">32553197</ArticleId>
            <ArticleId IdType="pmc">7381373</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
